2008 data FDA MAUDE openFDA FDA Class III

Inhibitor, Peridural Fibrosis (Adhesion Barrier)

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA MAUDE casebook

openFDA event book Inhibitor, Peridural Fibrosis LIGHT-BOOK · MAUDE

#935 of 1000 · 440 reports · 1999–2008

  • BOOK 440 reports
  • RANK #935 of 1000
  • DEATH 2 death-typed
  • INJ 420 injury-typed
  • MALF 5 malfunction
  • SPAN 1999–2008
  • PEAK 2001: 324
  • PHOTO Resectoscope

Nearest event-volume peer: Resectoscope, Working Element (0 report gap)

Inhibitor, Peridural Fibrosis (Adhesion Barrier) sits #935 of 1000 among tracked device types with 440 MAUDE reports spanning 1999–2008. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Similar-volume device →

Injury-coded reports run above the device-type norm

Inhibitor, Peridural Fibrosis carries 95.5% INJURY-coded reports, 65.2pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 0.5% corpus 1.5% · below corpus mean (-1.1 pp)
  • INJ 95.5% corpus 30.3% · above corpus mean (+65.2 pp)
  • MALF 1.1% corpus 64.8% · below corpus mean (-63.7 pp)

Lead product-problem code Device remains implanted is 45% of coded problems · Top event location is 89% of location-tagged rows .

Inhibitor, Peridural Fibrosis in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Inhibitor, Peridural Fibrosis (Adhesion Barrier) carries 440 MAUDE reports, ranked #935 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Injury 420 (95.5%)
Other 10 (2.3%)
Malfunction 5 (1.1%)
3 (0.7%)
Death 2 (0.5%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 267 (55.4%)
Other 83 (17.2%)
Hospitalization 60 (12.4%)
R 38 (7.9%)
19 (3.9%)
Life Threatening 9 (1.9%)
L 2 (0.4%)
Death 2 (0.4%)
O 1 (0.2%)
S 1 (0.2%)

Top Product Problems

Device remains implanted 213
Unknown (for use when the device problem is not known) 144
Reaction 46
Other (for use when an appropriate device code cannot be identified) 20
Device Issue 14
Replace 13
Repair 5
Device, removal of (non-implant) 4
Contamination 3
Explanted 2
Leak/Splash 2
Material Separation 2
Delivered as Unsterile Product 1
Difficult to Insert 1
Difficult to Remove 1
Fluid/Blood Leak 1
Loss of or Failure to Bond 1
Migration or Expulsion of Device 1
Out-Of-Box Failure 1
Particulates 1

Yearly Trend

99
1999: 4
00
2000: 83
01
2001: 324
02
2002: 22
03
2003: 6
08
2008: 1

Reports fell to 6 in 2003, down from an average of 173 in the two years before.

Related Entities for Inhibitor, Peridural Fibrosis (Adhesion Barrier)

Event Locations

391 (88.9%)
NOT APPLICABLE 32 (7.3%)
HOSPITAL 13 (3.0%)
UNKNOWN 4 (0.9%)

Nationwide devices with a comparable volume-and-death footprint

Two openFDA-derived peer sets for Inhibitor, Peridural Fibrosis: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (440 here).

Similar death-typed counts

Nearest other device types by death-typed report count (2 here), distinct from the volume row.

Disclaimer: MAUDE figures for Inhibitor, Peridural Fibrosis are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Inhibitor, Peridural Fibrosis; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.